Page 2 - Best Prostate cancer doctors in Istanbul: TOP 29 doctors

Dr. Ozden brings over 20 years of medical experience, specializing in prostate cancer treatment at VM Medical Park Pendik Hospital.

• Graduated from Istanbul University's prestigious Cerrahpaşa Faculty of Medicine
• Completed medical oncology subspecialty at Kocaeli University
• Extensive experience in internal medicine before focusing on oncology

Professor Gul Alco specializes in radiation oncology for prostate cancer at Istanbul Medipol University.

• Over 20 years of experience in radiation oncology
• Associate Professor and later Professor at Demiroglu Bilim University
• Completed residency at Kadir Has University
• Works at Medipol Acibadem District Hospital

Dr. Sertkaya specializes in Andrology, focusing on male reproductive and urological health, including prostate cancer. He earned the title 'FEBU' from the European Association of Urology.

• Associate Professor of Urology since 2020
• Completed urology specialization at Haydarpaşa Numune Training and Research Hospital
• Founded Andro Expertise Male Health and Aesthetics Center in 2022
• Attended training sessions with leading Andrology professors worldwide

900+ oncology treatments performed – Prof. Sezer Saglam specializes in targeted therapies for prostate cancer at Istanbul Florence Nightingale Hospital.

• 28 years of experience in medical oncology
• Professor since 2016 with research influencing global protocols
• Member of ASCO, ESMO, and European Neuroendocrine Tumour Society
• Leads clinical trials in precision medicine for oncology
• Uses GA68 PET PSMA scans for personalized treatment plans

Over 2500 MR-Linac radiotherapy sessions – Assoc. Prof. Turkkan specializes in advanced radiotherapy techniques at Hisar Hospital Intercontinental.

• 16 years of experience in radiation oncology
• Expert in stereotactic and MRI-guided radiotherapy
• Member of ESTRO and TROD
• Published 27 articles and 5 book chapters
• Clinical researcher at Maastricht University's MAASTRO Clinic

Professor Cemil Bilir combines academic expertise in medical oncology with international training – including research at Northeastern University in Boston.

• Specialized in medical oncology with 13+ years of experience
• Member of ASCO, ESMO, and TTOD – leading oncology societies
• Current professor at Sakarya University Faculty of Medicine
• Trained at Cleveland Clinic for rheumatology and gastroenterology

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.